Identification of AGE-precursors and AGE formation in glycation-induced BSA peptides

Journal of Biochemistry and Molecular Biology

Volumn 41, Issue 7, 2008, Pages 516-522

  Ahmad, Waqar ^a   Li, Lili ^a   Deng, Yulin ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

AGEs; Bovine serum albumin; Glycated peptides; Mass spectrometry

Indexed keywords

BOVINAE;

EID: 49149130648     PISSN: 12258687     EISSN: 02191024     Source Type: Journal    
DOI: 10.5483/bmbrep.2008.41.7.516     Document Type: Article

References (35)

1. Brownlee, M., Cerami, A., and Vlassara H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315-1321.
2. Nwabuisi, C. (2002) Prophylactic effect of multi-herbal extract 'Agbo-Iba' on malaria induced in mice. East Afr. Med. J. 79, 343-346.
3. Reynolds, T. M. (1963) Chemistry of nonenzymatic browning. I. The reaction between aldose and amines. Adv. Food Res. 12, 1-52.
4. Huh, J. W., Yang, S. J., Hwang, E. Y., Choi, M. M., Lee, H. J., Kim, E. A., Choi, S. Y., Choi, J., Hong, H. N. and Cho, S. W. (2007) Alteration of the quaternary structure of human UDP-glucose dehydrogenase by a double mutation. J Biochem. Mol. Biol. 40, 690-696.
5. Reynolds, T. M. (1965) Chemistry of nonenzymatic browning. II. Adv. Food Res. 14, 167-283.
6. Kato, H., Cho, R. K., Okitani, A. and Hayase, F. (1987 ) Responsibility of 3-deoxyglucosone for the glucose-induced polymerization of proteins. Agric. Biol. Chem. 51, 683-689.
7. Park, J., Kim, S., Oh, J. K., Kim, J. Y., Yoon, S. S., Lee, D. and Kim, Y. (2005) Identification of differentially expressed proteins in imatinib mesylate-resistant chronic myelogenous cells. J. Biochem. Mol. Biol. 38, 725-738.
8. Baynes, J. W. (2004) The clinical chemome: a tool for the diagnosis and management of chronic disease. Clin. Chem. 50, 1116-1117.
9. Lee, A. Y., Chung, S. K. and Chung, S. S. (1995) Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc. Natl. Acad. Sci. U.S.A. 92, 2780-2784.
10. Chen, L., Yang, Y., Han, J., Zhang, B. Y., Zhao, L., Nie, K., Wang, X. F., Li, F., Gao, C., Dong, X. P. and Xu, C. M. (2007) Removal of the glycosylation of prion protein provokes apoptosis in SF126. J. Biochem. Mol. Biol. 40, 662-669.
11. Koya, D. and King, G. (1998) Protein kinase C activation and the development of diabetic complications. Diabetes. 47, 859-866.
12. Kolm-Litty, V., Sauer, U., Nerlich, A., Lehmann, R. and Schleicher, E. D. (1998) High glucose-induced transforming growth factor fetal production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J. Clin. Invest. 101, 160-169.
13. Sing, R., Barden, A., Mori, T. and Beilin, L. (2001) Advanced glycation endproducts: a review. Diabetologia. 44, 129-146.
14. Kohn, R. R., Cerami, A. and Monnier, V. M. (1984) Collagen aging in vitro by nonenzymatic glycosylation and browning. Diabetes. 33. 57-59.
15. Wu, J. T. (1993) Advanced glycosylation end products: a new disease marker for diabetes and aging. J. Clin. Lab. Anal. 7, 252-255.
16. Beisswenger, P. J., Makita, Z., Cuphrey, T. J., Moore, L. L., Jean, S., Brinck-Johnsen, T., Bucala, R. and Vlassara, H. (1995) Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44, 824-829.
17. Wu, J. T. (1993) Review of diabetes: identification of markers for early detection, glycemic control, and monitoring clinical complications. J. Clin. Lab. Anal. 7, 293-300.
18. Korbet, S. M., Makita, Z., Firanek, C. A. and Vlassara, H. (1993) Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patients. Am. J. Kidney Dis. 22, 588-591.
19. Makita, Z., Vlassara, H., Cerami, A. and Bucala, R. (1992) Immunochemical detection of advanced glycosylation end products in vivo. J. Biol. Chem. 267, 5133-5138.
20. Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A. and Vlassara, H. (1991) Advanced glycosylation end products in patients with diabetic nephropathy. N. Engl. J. Med. 325, 836-842.
21. Vlassara, H. (1994) Recent progress on the biologic and clinical significance of advanced glycosylation end prod. J. Lab. Clin. Med. 124, 19-30.
22. Thorpe, S. R and Baynes, J. W. (1996) Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging. 9, 69-77.
23. Yim, M. B, Yim, H. S, Lee, C., Kang, S. O. and Chock, P. B. (2001) Protein glycation: creation of catalytic sites for free radical generation. Ann. N.Y. Acad. Sci. 928, 48-53.
24. Makita, Z., Vlassara, H., Rayfield, E., Cartwright, K., Friedman, E., Rodby, R., Cerami, A. and Bucala, R. (1992) Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science 258, 651-653.
25. Gaskel, S. J. (1986) Mass spectrometry in biomedical research, John Wiley & Sons, New York, U.S.A.
26. Brownlee, M., Vlassara, H. and Cerami, A. (1984) Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 101, 527-537.
27. Sebekova, K., Kupcova, V., Schinzel, R. and Heidland, A. (2002), Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis-amelioration by liver transplantation. J. Hepatol. 36, 66-71.
28. Thornalley, P. J, Battah, S., Ahmed, N., Karachalias, N., Agalou, S., Babaei-Jadidi, R. and Dawnay, A. (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem. J. 375, 581-592.
29. Niwa, T. (1997) Mass spectrometry in the search for uremic toxins. Mass Spectrom. Rev. 16, 307-332.
30. Zhang, Y., Cocklin, R. R., Bidasee, K. R. and Wang, M. (2003) Rapid determination of advanced glycation end products of proteins using MALDI-TOF-MS and PERL script peptide searching algorithm. J. Biomol. Tech. 14, 224-230.
31. Furth, A., J. (1997) Glycated proteins in diabetes. Br. J. Biomed. Sci. 54, 192-200.
32. Lapolla, A., Traldi, P. and Fedele, D. (2005) Importance of measuring products of non-enzymatic glycation of proteins. Clin. Biochem. 38, 103-115.
33. Chen, S., Cohen, M. P., Lautenslager, G. T., Shearman, C. W. and Ziyadeh, F. N. (2001) Glycated albumin stimulates TGF-beta 1 production and protein kinase C actvity in glomerular endothelial cells. Kidney Int. 59, 673-681.
34. Chen, S., Chen, M. P. and Ziyadeh, F. N. (2000) Amadoriglycated albumin in diabetic nephropathy: patophysiologic connections. Kidney Int. Suppl. 77, S40-S44.
35. Schalkwijk, C. G., Chatuverdi, N., Twaafhoven, H., van Hinsbergh, V. W. and Stehouwer, C. D. (2002) Amadori albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetes. Eur .J. Clin. Invest. 32, 500-506.